---
title: "Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device"
date: "2024-07-05T10:01:55.000Z"
publishedDate: "5 juillet 2024"
summary: "Investment in a programme of clinical trials will underpin Boston Scientific’s strategy to expand the uptake of its Watchman left atrial appendage closure (LAAC) device, the company’s global vice president and general manager for the Watchman system, Angelo De Rosa, has told Cardiovascular News. De Rosa took over the Watchman team within Boston in September [&#8230;] The post Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/medtech-insight-watchman/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-07-05-medtech-insights-trial-pipeline-underpins-growth-strategy-for-watchman-laac-device"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/07/Angelo-DE-ROSA_landscape.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtech-insight-watchman/"
---

![Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/07/Angelo-DE-ROSA_landscape.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtech-insight-watchman/*

## L’essentiel

Investment in a programme of clinical trials will underpin Boston Scientific’s strategy to expand the uptake of its Watchman left atrial appendage closure (LAAC) device, the company’s global vice president and general manager for the Watchman system, Angelo De Rosa, has told Cardiovascular News. De Rosa took over the Watchman team within Boston in September [&#8230;] The post Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/medtech-insight-watchman/
